Rp-8-Bromo-beta-phenyl-1,N2-ethenoguanosine 3,5-cyclic monophosphorothioate sodium salt, >=98% (HPLC

Rp-8-Bromo-beta-phenyl-1,N2-ethenoguanosine 3,5-cyclic monophosphorothioate sodium salt, >=98% (HPLC

Biochem/physiol Actions

Rp-8-Br-PET-cGMPS is metabolically stable, competitive inhibitor of cGMP-dependent protein kinase G. Inhibits both PKG I (Ki?=?30 nM) and PKG II and blocks cGMP-gated retinal type ion channels (IC50?=?25 micromoles).

Features and Benefits

This compound is featured on the PKA & PKG page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

Legal Information

U.S. Patent 5,625,056, DE Patent 4,217,679.

Packaging

1, 5 mg in glass bottle

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Quality Level mp InChI key InChI Manufacturer Form Assay Price
3573287 Rp-8-Bromo-beta-phenyl-1,N2-ethenoguanosine 3,5-cyclic monophosphorothioate sodium salt, >=98% (HPLC white to beige 100 240-300 °C (lit.) SVMPQLHYWRTQCX-DBHVCDLJSA-M 1S/C18H15BrN5O6PS.Na/c19-17-21-11-14(24(17)16-12(25)13-10(29-16)7-28-31(27,32)30-13)22-18-20-9(6-23(18)15(11)26)8-4-2-1-3-5-8;/h1-6,10,12-13,16,25H,7H2,(H,20,2 SIGMA-ALDRICH powder ≥98% (HPLC)
You need to be logged in to see prices.
3573288 Rp-8-Bromo-beta-phenyl-1,N2-ethenoguanosine 3,5-cyclic monophosphorothioate sodium salt, >=98% (HPLC white to beige 100 240-300 °C (lit.) SVMPQLHYWRTQCX-DBHVCDLJSA-M 1S/C18H15BrN5O6PS.Na/c19-17-21-11-14(24(17)16-12(25)13-10(29-16)7-28-31(27,32)30-13)22-18-20-9(6-23(18)15(11)26)8-4-2-1-3-5-8;/h1-6,10,12-13,16,25H,7H2,(H,20,2 SIGMA-ALDRICH powder ≥98% (HPLC)
You need to be logged in to see prices.
You need to be logged in to see prices.